Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the "Exchange Act") and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. § 1350), Marc de Garidel, President and Chief Executive Officer of CinCor Pharma, Inc. (the "Company"), and Mary Theresa Coelho, Chief Financial Officer and Chief Business Development Officer of the Company, each hereby certifies that, to the best of his/her knowledge:
Date: August 8, 2022 |
| By: | /s/ Marc de Garidel |
|
|
| Marc de Garidel |
|
|
| Chief Executive Officer |
|
|
| (Principal Executive Officer) |
|
|
|
|
|
|
| /s/ Mary Theresa Coelho |
|
|
| Mary Theresa Coelho |
|
|
| EVP, Chief Financial Officer and Chief Business Development Officer |
|
|
| (Principal Financial Officer and Principal Accounting Officer) |